LONDON, 29 March 2026 - For immediate release

Euro Biom has launched as a UK-based MHRA-licensed pharmaceutical wholesale distributor, supplying licensed medicines sourced from the UK to healthcare institutions across the GCC, Africa, Europe, CIS, and Asia. Headquartered in Harmondsworth, London - near Heathrow - the company holds a Wholesale Dealer Authorisation (WDA) issued by the Medicines and Healthcare products Regulatory Agency (MHRA) and operates in line with Good Distribution Practice (GDP) guidelines.

The company is set up to export to hospitals, government health ministries, NGOs, and private healthcare groups across more than 40 countries, with a particular focus on markets in the Gulf Cooperation Council and Sub-Saharan Africa where access to reliable, compliant UK-sourced pharmaceutical supply has historically been limited.

Specialist Supply Capability

Euro Biom has built its operations around the complex end of pharmaceutical supply - shortage situations, UK-licensed medicines supplied for named-patient import into destination markets, urgent institutional procurement, and hard-to-source products that conventional wholesale channels do not routinely handle. Shipments are supported by chain of custody documentation and batch traceability from source to destination.

Compliance documents including WDA certificates and GDP records are available on request for supplier due diligence by healthcare institutions, government procurement bodies, and international NGOs.

"Access to quality medicines should not be determined by geography. Our MHRA authorisation allows us to connect the UK pharmaceutical supply chain with healthcare buyers in markets where reliable, compliant supply is most needed."

- Shikhar Bhatt, Head of Operations, Euro Biom

Serving GCC and African Healthcare Markets

The GCC and African healthcare markets represent a significant and growing demand for UK-sourced medicines. MHRA-licensed provenance and GDP-compliant 2-8°C cold chain logistics are increasingly required by hospital procurement teams and health ministry buyers in these regions - particularly for oncology, HIV, cardiovascular, and critical care medicines.

Euro Biom's office near Heathrow gives access to international air freight routes for urgent orders and 2-8°C shipments, arranged with specialist carriers.

Regulatory Standing

Euro Biom operates under the following regulatory framework:

  • MHRA Wholesale Dealer Authorisation (WDA) - UK-issued, current
  • Good Distribution Practice (GDP)
  • UK-licensed medicine supply for named-patient import under destination-country frameworks
  • Chain of custody documentation supporting each shipment
  • Batch traceability from manufacturer to end destination

For verified healthcare institutions: Supplier due diligence documentation including WDA certificates and GDP records is available on request. Contact work@eurobiom.co.uk or submit an enquiry via the website.

Also Published On

This press release has been distributed on the following newswire platforms: OpenPR and PRLog.

About Euro Biom

Euro Biom Ltd is an MHRA-licensed pharmaceutical wholesale distributor based in Harmondsworth, London. The company holds a Wholesale Dealer Authorisation and exports licensed medicines sourced from the UK to hospitals, health ministries, NGOs and private healthcare institutions across the GCC, Africa, Europe, CIS and Asia. Euro Biom specialises in UK-licensed medicines for named-patient import, shortage supply, and complex institutional procurement. Company No. 15380737. Registered in England and Wales.

Submit a Product Enquiry

We supply verified healthcare institutions globally. Tell us what you need and our team will respond the same working day.

Contact Our Team